Research outputs

  1. 2019
  2. The Gut Microbiome Influences Responses to Programmed Death 1 Therapy in Chinese Lung Cancer Patients — the Benefits of Diversity

    Bernicker, E. H. & Quigley, E. M., Aug 1 2019, In : Journal of Thoracic Oncology. 14, 8, p. 1319-1322 4 p.

    Research output: Contribution to journalEditorial

  3. Combined blockade of activating ERBB2 mutations and ER results in synthetic lethality of ERþ/HER2 mutant breast cancer

    Croessmann, S., Formisano, L., Kinch, L. N., Gonzalez-Ericsson, P. I., Sudhan, D. R., Nagy, R. J., Mathew, A., Bernicker, E. H., Cristofanilli, M., He, J., Cutler, R. E., Lalani, A. S., Miller, V. A., Lanman, R. B., Grishin, N. V. & Arteaga, C. L., Jan 1 2019, In : Clinical Cancer Research. 25, 1, p. 277-289 13 p.

    Research output: Contribution to journalArticle

  4. Disparities in the Treatment and Outcome of Stage I Non–Small-Cell Lung Cancer in the 21st Century

    Dalwadi, S. M., Lewis, G. D., Bernicker, E. H., Butler, E. B., Teh, B. S. & Farach, A. M., Jan 1 2019, (Accepted/In press) In : Clinical Lung Cancer.

    Research output: Contribution to journalArticle

  5. Relationship between clinical features, GEP class, and PRAME expression in uveal melanoma

    Schefler, A. C., Koca, E., Bernicker, E. H. & Correa, Z. M., Jan 1 2019, In : Graefe's Archive for Clinical and Experimental Ophthalmology.

    Research output: Contribution to journalReview article

  6. Update on emerging biomarkers in lung cancer

    Bernicker, E. H., Allen, T. C. & Cagle, P. T., Jan 1 2019, In : Journal of Thoracic Disease. 11, p. S81-S88

    Research output: Contribution to journalReview article

  7. 2018
  8. Correlation between programmed death receptor-1 expression in tumor-infiltrating lymphocytes and programmed death ligand-1 expression in non-small cell lung carcinoma

    Monroig-Bosque, P. D. C., Driver, B., Morales-Rosado, J. A., Deavers, M., Tacha, D., Bernicker, E., Cagle, P. T. & Miller, R. A., Nov 1 2018, In : Archives of Pathology and Laboratory Medicine. 142, 11, p. 1388-1393 6 p.

    Research output: Contribution to journalArticle

  9. Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors guideline from the college of American pathologists, the international association for the study of lung cancer, and the association for molecular pathology

    Lindeman, N. I., Cagle, P. T., Aisner, D. L., Arcila, M. E., Beasley, M. B., Bernicker, E. H., Colasacco, C., Dacic, S., Hirsch, F. R., Kerr, K., Kwiatkowski, D. J., Ladanyi, M., Nowak, J. A., Sholl, L., Temple-Smolkin, R., Solomon, B., Souter, L. H., Thunnissen, E., Tsao, M. S., Ventura, C. B. & 2 othersWynes, M. W. & Yatabe, Y., Mar 1 2018, In : Archives of Pathology and Laboratory Medicine. 142, 3, p. 321-346 26 p.

    Research output: Contribution to journalArticle

  10. Evaluation of the prescribing patterns, adverse effects, and drug interactions of oral chemotherapy agents in an outpatient cancer center

    Solomon, J. M., Ajewole, V. B., Schneider, A. M., Sharma, M. & Bernicker, E. H., Jan 1 2018, (Accepted/In press) In : Journal of Oncology Pharmacy Practice.

    Research output: Contribution to journalArticle

  11. Hybrid Capture–Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Non–Small Cell Lung Cancer

    Schrock, A. B., Welsh, A., Chung, J. H., Pavlick, D., Bernicker, E. H., Creelan, B. C., Forcier, B., Ross, J. S., Stephens, P. J., Ali, S. M., Dagogo-Jack, I., Shaw, A. T., Li, T., Ou, S. H. I. & Miller, V. A., Jan 1 2018, (Accepted/In press) In : Journal of Thoracic Oncology.

    Research output: Contribution to journalArticle

  12. Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors. Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

    Lindeman, N. I., Cagle, P. T., Aisner, D. L., Arcila, M. E., Beasley, M. B., Bernicker, E., Colasacco, C., Dacic, S., Hirsch, F. R., Kerr, K., Kwiatkowski, D. J., Ladanyi, M., Nowak, J. A., Sholl, L., Temple-Smolkin, R., Solomon, B., Souter, L. H., Thunnissen, E., Tsao, M. S., Ventura, C. B. & 2 othersWynes, M. W. & Yatabe, Y., 2018, (Accepted/In press) In : Journal of Molecular Diagnostics.

    Research output: Contribution to journalArticle

  13. Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors. Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

    Lindeman, N. I., Cagle, P. T., Aisner, D. L., Arcila, M. E., Beasley, M. B., Bernicker, E., Colasacco, C., Dacic, S., Hirsch, F. R., Kerr, K., Kwiatkowski, D. J., Ladanyi, M., Nowak, J. A., Sholl, L., Temple-Smolkin, R., Solomon, B., Souter, L. H., Thunnissen, E., Tsao, M. S., Ventura, C. B. & 2 othersWynes, M. W. & Yatabe, Y., 2018, (Accepted/In press) In : Journal of Thoracic Oncology.

    Research output: Contribution to journalArticle

  14. 2017
  15. Programmed death ligand-1 (pd-l1) expression in either tumor cells or tumor-infiltrating immune cells correlates with solid and high-grade lung adenocarcinomas

    Driver, B. R., Miller, R. A., Miller, T., Deavers, M., Gorman, B., Mody, D., Ge, Y., Barrios, R., Bernicker, E., Kim, M. & Cagle, P. T., Nov 1 2017, In : Archives of Pathology and Laboratory Medicine. 141, 11, p. 1529-1532 4 p.

    Research output: Contribution to journalArticle

  16. Biomarkers for selection of therapy for adenocarcinoma of the lung

    Bernicker, E. H., Miller, R. A. & Cagle, P. T., Apr 1 2017, In : Journal of Oncology Practice. 13, 4, p. 221-227 7 p.

    Research output: Contribution to journalReview article

  17. Practice Patterns and Outcomes in Elderly Stage I Non-Small-cell Lung Cancer: A 2004 to 2012 SEER Analysis

    Dalwadi, S. M., Szeja, S. S., Bernicker, E. H., Butler, E. B., Teh, B. S. & Farach, A. M., 2017, (Accepted/In press) In : Clinical Lung Cancer.

    Research output: Contribution to journalArticle

  18. 2016
  19. First-line immune therapy - Implications for pathologists

    Miller, R. A., Cagle, P. T. & Bernicker, E. H., Aug 1 2016, In : Archives of Pathology and Laboratory Medicine. 140, 8, p. 739-740 2 p.

    Research output: Contribution to journalArticle

  20. Chemotherapy in non-small cell lung cancer: opportunities for advancement

    Akhtari, M., Bernicker, E. H. & Teh, B. S., Jun 23 2016, In : Chinese Journal of Lung Cancer. 35, 1, p. 56 1 p.

    Research output: Contribution to journalArticle

  21. Impact of recent developments in lung cancer on the practice of pathology

    Cagle, P. T., Allen, T. C., Bernicker, E. H., Ge, Y., Haque, A. & Barrios, R., Apr 1 2016, In : Archives of Pathology and Laboratory Medicine. 140, 4, p. 322-325 4 p.

    Research output: Contribution to journalArticle

  22. Next-generation sequencing of a cohort of pulmonary large cell carcinomas reclassified by world health organization 2015 criteria

    Driver, B. R., Portier, B. P., Mody, D. R., Deavers, M., Bernicker, E. H., Kim, M. P., Teh, B. S., Santacruz, J. F., Kopas, L., Munden, R. F. & Cagle, P. T., Apr 1 2016, In : Archives of Pathology and Laboratory Medicine. 140, 4, p. 312-317 6 p.

    Research output: Contribution to journalArticle

  23. Next-generation sequencing and immunotherapy biomarkers: A medical oncology perspective

    Bernicker, E., Mar 1 2016, In : Archives of Pathology and Laboratory Medicine. 140, 3, p. 245-248 4 p.

    Research output: Contribution to journalArticle

  24. 2015
  25. Challenges to biomarker testing for PD-1/PD-L1 checkpoint inhibitors for lung cancer

    Cagle, P. T. & Bernicker, E. H., Dec 1 2015, In : Archives of Pathology and Laboratory Medicine. 139, 12, p. 1477-1478 2 p.

    Research output: Contribution to journalArticle

  26. A new immunotherapy drug creates a watershed for the surgical pathologist's role in patient care

    Cagle, P. T. & Bernicker, E. H., Nov 1 2015, In : Archives of Pathology and Laboratory Medicine. 139, 11, p. 1329-1330 2 p.

    Research output: Contribution to journalArticle

  27. Biomarker testing in non-small cell lung cancer: A clinician's perspective

    Bernicker, E. H., Apr 1 2015, In : Archives of Pathology and Laboratory Medicine. 139, 4, p. 448-450 3 p.

    Research output: Contribution to journalArticle

  28. Therapy

    Bernicker, E. H., Gaur, P., Desai, S., Teh, B. S. & Blackmon, S. H., Jan 1 2015, Diffuse Malignant Mesothelioma. Springer New York, p. 125-139 15 p.

    Research output: Chapter in Book/Report/Conference proceedingChapter

  29. 2010
  30. Cardiac chloroma: Novel presentation and subsequent diagnosis with cardiac magnetic resonance imaging

    Attallah, A., Cheong, B. Y. C., Bernicker, E. & Wilson, J. M., Aug 13 2010, In : Texas Heart Institute Journal. 37, 2, p. 242-243 2 p.

    Research output: Contribution to journalArticle

  31. 1996
  32. Unanticipated diagnoses found at autopsy in an urban public teaching hospital

    Bernicker, E. H., Atmar, R. L., Schaffner, D. L. & Greenberg, S. B., May 1 1996, In : American Journal of the Medical Sciences. 311, 5, p. 215-220 6 p.

    Research output: Contribution to journalArticle

  33. 1994
  34. Case report: transverse myelitis associated with Epstein-Barr virus infection.

    Caldas, C., Bernicker, E. H., Nogare, A. D. & Luby, J. P., Jan 1 1994, In : American Journal of the Medical Sciences. 307, 1, p. 45-48 4 p.

    Research output: Contribution to journalArticle

  35. 1990
  36. Interim meeting report

    Bernicker, E. H., Jan 1 1990, In : Journal of the American Medical Association. 263, 5

    Research output: Contribution to journalArticle

  37. The House of God

    Shem, S. & Bernicker, E. H., Jan 1 1990, In : Journal of the American Medical Association. 264, 13

    Research output: Contribution to journalArticle

  38. 1989
  39. Photodynamic therapy triggers cytotoxic drug retained to greater degree by cancer cells.

    Bernicker, E. H., Nov 10 1989, In : Journal of the American Medical Association. 262, 18

    Research output: Contribution to journalArticle

  40. Should we legalize drugs?

    Bernicker, E. H., Apr 28 1989, In : Journal of the American Medical Association. 261, 16

    Research output: Contribution to journalArticle

  41. Yes and no

    Bernicker, E. H., Jan 1 1989, In : Journal of the American Medical Association. 262, 21

    Research output: Contribution to journalArticle

  42. 1987
  43. [2]Calcimedins: Purification and production of antibodies

    Mathew, J. K., Scully, R. R., Smith, V. L., Bernicker, E. H. & Dedman, J. R., Dec 1 1987, In : Methods in enzymology. 139, C, p. 19-30 12 p.

    Research output: Contribution to journalArticle

ID: 2284139